Fortis Healthcare vs Global Health: Share Price, Valuation and Results Compared

Fortis Healthcare Ltd. (NSE: FORTIS) and Global Health Ltd (Medanta) (NSE: MEDANTA) are both listed in the Hospitals and Healthcare Centers industry. Fortis Healthcare has a market capitalisation of ₹58,283 Cr and Global Health ₹38,422 Cr, as of 16 Nov 2026. Their P/E ratios are 55.1 and 69.7 respectively. Return on equity is 11.01% for Fortis Healthcare and 15.03% for Global Health. Over one year, Fortis Healthcare's share price is down 25.1% and Global Health's is up 16.2%.

Fortis Healthcare vs Global Health — Key Figures

MetricFortis HealthcareGlobal Health
NSE SymbolFORTISMEDANTA
BSE Code532843543654
Share Price₹764.00₹1,453.00
Market Cap₹58,283 Cr₹38,422 Cr
P/E Ratio55.169.7
Return on Equity11.01%15.03%
Return on Assets6.84%8.22%
Dividend Yield0.13%0.03%
Beta (1Y)0.460.17
1-Year Price Change-25.1%+16.2%
3-Month Price Change-15.7%+3.1%
52-Week Range₹704.95 – ₹1,010.10₹956.00 – ₹1,544.00
Latest QuarterQ2 FY27Q2 FY27
Quarterly Revenue₹2,735 Cr₹1,469 Cr
Quarterly Net Profit₹320 Cr₹219 Cr
Net Margin11.7%14.9%
EPS (Basic, Quarter)₹4.14₹8.21
Results Basisconsolidatedconsolidated
HeadquartersGurugram, HaryanaGurugram, Haryana

The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.

About the Companies

Fortis Healthcare Ltd.

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surg…

Global Health Ltd (Medanta)

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology an…

Frequently Asked Questions

Which is larger by market cap, Fortis Healthcare or Global Health?

Fortis Healthcare has a market capitalisation of ₹58,283 Cr, against ₹38,422 Cr for Global Health as of 16 Nov 2026, about 1.5 times the size by market cap.

What is the P/E ratio of Fortis Healthcare and Global Health?

Fortis Healthcare has a P/E of 55.1 and Global Health a P/E of 69.7 as of 16 Nov 2026.

What is the return on equity of Fortis Healthcare and Global Health?

Fortis Healthcare has a return on equity of 11.01% and Global Health 15.03%.

How have Fortis Healthcare and Global Health shares moved over one year?

Fortis Healthcare's share price is down 25.1% over one year and Global Health's is up 16.2%.

What were the latest quarterly results of Fortis Healthcare and Global Health?

Fortis Healthcare reported revenue of ₹2,735 Cr and net profit of ₹320 Cr for Q2 FY27. Global Health reported revenue of ₹1,469 Cr and net profit of ₹219 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.

Which industry are Fortis Healthcare and Global Health in?

Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.

Is this comparison a recommendation to buy or sell Fortis Healthcare or Global Health?

No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.

More Comparisons

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.